electroCore (ECOR) Net Cash Flow Growth (1y) (2018 - 2026)
electroCore (ECOR) Net Cash Flow Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.82 Bn | 176.53 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.59 Bn | 67.14 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 28.11 Bn | 25.82 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.28 Bn | 21.15 Bn | 2.07 Bn | 76.43% |
| 10 | electroCore | 55,240.01 | -8.77 Mn | 8.36 Mn | -878.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -878.93% |
| Dec 31, 2025 | 94.21% |
| Sep 30, 2025 | 746.83% |
| Jun 30, 2025 | -105.69% |
| Mar 31, 2025 | 110.95% |
| Dec 31, 2024 | -66.13% |
| Sep 30, 2024 | -223.18% |
| Jun 30, 2024 | -54.46% |
| Mar 31, 2024 | 56.35% |
| Dec 31, 2023 | 178.70% |
| Sep 30, 2023 | 148.32% |
| Jun 30, 2023 | 564.24% |
| Mar 31, 2023 | -22.59% |
| Dec 31, 2022 | -19.57% |
| Sep 30, 2022 | -119.76% |
| Jun 30, 2022 | -157.62% |
| Mar 31, 2022 | -202.11% |
| Dec 31, 2021 | -108.26% |
| Sep 30, 2021 | 313.03% |
| Jun 30, 2021 | 1,146.87% |